总部位于柏林inne已经筹集了1000万美元refe是什么公司rring to as an extension of a 2019 Series A round. The health tech startup produces a saliva biosensor mini-lab that can be used by women to track progesterone levels within their bodies.
一个lready in use by thousands of customers across Europe, Inne’s new $10 million raise will specifically aid the company to expand the platform and enter the US market through an exclusive partnership with Phenology. To date, Inne has raised a total of $18.8 million.
Progesterone. On the list of chemicals floating around in your body, it’s a pretty important one. The one we’re perhaps most familiar with is progesterone’s role in the sex hormone involved in the menstrual cycle, and pregnancy cycle of mammals.
一个ccording to the startup, some users have used the service to help them get pregnant, while others have done just the opposite. To this end, Inne is currently in the process of achieving certification as a contraceptive product following the results of ongoing clinical studies.
“Women’s health is consistently one of the most under-funded areas of medical research, with women only officially required to be included in clinical research in the US for the first time in 1993. This means women have less information about what is happening to their bodies and that makes it harder for them to improve their health and lifestyle. This information gap has been a driving force for me in creating inne and I’m thrilled that we are now able to help women learn about their bodies and be proactive in managing their own health and fertility,” commented Inne founder and CEOEirini Rapti。
Inne的1000万美元系列A延伸回合由DSM冒险， 和博士基基金，，，，平息风暴冒险和天使投资者Taavet Hinrikus（明智的），Fiona Pathiraja博士， 和Rolf Schroemgens（Trivago）所有参与。
“该产品最适合用于激素水平的家庭测试。在短时间内，Inne已被证明会带领妇女量化自我分解的趋势。我们很热情，因为从生育到避孕和围绝经期的多种用例，” Borski Fund的总结说Simone Brummelhuis。